MAIN CONTENT
Finding a missing link in the movement of tau
In a healthy brain, tau helps stabilize microtubules, structural components that support nerve-cell organization and activity. When tau changes abnormally, however, it can accumulate in forms associated with neuronal injury. In Alzheimer’s disease and other tau-related neurodegenerative disorders, the distribution of abnormal tau is closely linked to worsening brain function. Understanding how it passes from one cell to another is consequently an important question rather than a minor molecular detail.
A team led by Chulman Jo at the Korea National Institute of Health examined brain tissue collected after death and nerve cells generated from the stem cells of people with Alzheimer’s disease. Both settings showed higher FAM84B levels in relevant disease-associated samples than in comparisons without dementia. These approaches provide complementary forms of evidence: human tissue reflects features of actual illness, while cell-based systems allow scientists to study individual processes more closely. Elevated protein levels alone, however, cannot demonstrate that a molecule caused the disease.
The decisive experimental observation came when researchers deliberately increased FAM84B in cells. They recorded more tau released outside those cells and more nearby recipient cells receiving it. This supports the idea that FAM84B participates in the export and intercellular movement of tau, rather than merely accompanying an existing disease state. Precisely how much that laboratory phenomenon contributes to symptoms in living people is still unknown.















